相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model
Hanwen Wang et al.
ROYAL SOCIETY OPEN SCIENCE (2019)
A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer
Mohammad Jafarnejad et al.
AAPS JOURNAL (2019)
Improving the generation and selection of virtual populations in quantitative systems pharmacology models
Theodore R. Rieger et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2018)
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
Chung-Han Lee et al.
TRENDS IN IMMUNOLOGY (2018)
Advances in personalized cancer immunotherapy
Kazuhiro Kakimi et al.
BREAST CANCER (2017)
A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition
Chang Gong et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma
Manuel Fankhauser et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
Stephan Halle et al.
TRENDS IN IMMUNOLOGY (2017)
CTLA-4 blockade with ipilimumab increases peripheral CD8+ T cells: Correlation with clinical outcomes.
A. Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Nivolumab Exposure-Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non-Small Cell Lung Cancer
Yan Feng et al.
CLINICAL CANCER RESEARCH (2017)
QSP Toolbox: Computational Implementation of Integrated Workflow Components for Deploying Multi-Scale Mechanistic Models
Yougan Cheng et al.
AAPS JOURNAL (2017)
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential
Gregory T. Wurz et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Sequential immunotherapy regimens-expect the unexpected
Patricio Serra-Bellver et al.
LANCET ONCOLOGY (2016)
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel et al.
CELL (2015)
T-cell repertoire The human T-cell repertoire grows up
James J. Moon et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Somatic mutation in cancer and normal cells
Inigo Martincorena et al.
SCIENCE (2015)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
A Quantitative Systems Pharmacology Perspective on Cancer Immunology
Christina Byrne-Hoffman et al.
PROCESSES (2015)
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
Jason Madore et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Modeling the T cell immune response: a fascinating challenge
Penelope A. Morel et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Survey of monoclonal antibody disposition in man utilizing a minimal physiologically-based pharmacokinetic model
Yanguang Cao et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Modeling cancer-immune responses to therapy
L. G. dePillis et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models
Sirus Palsson et al.
BMC SYSTEMS BIOLOGY (2013)
Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma
Jason J. Luke et al.
CANCER (2013)
Structure and Interactions of the Human Programmed Cell Death 1 Receptor
Xiaoxiao Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The integration of T cell migration, differentiation and function
David Masopust et al.
NATURE REVIEWS IMMUNOLOGY (2013)
How many dendritic cells are required to initiate a T-cell response?
Susanna Celli et al.
BLOOD (2012)
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
Esdy N. Rozali et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
The High Cost of Cancer Drugs and What We Can Do About It
Mustaqeem Siddiqui et al.
MAYO CLINIC PROCEEDINGS (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies
Stacey D. Finley et al.
BMC SYSTEMS BIOLOGY (2011)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses
Emily Corse et al.
JOURNAL OF IMMUNOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Single-Institution Experience With Ipilimumab in Advanced Melanoma Patients in the Compassionate Use Setting Lymphocyte Count After 2 Doses Correlates With Survival
Geoffrey Y. Ku et al.
CANCER (2010)
Chemokines Can Effector Cells Be Redirected to the Site of the Tumor?
Steven M. Dubinett et al.
CANCER JOURNAL (2010)
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma
Xiaohong Shen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Greg M. Thurber et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation
Sarah E. Henrickson et al.
NATURE IMMUNOLOGY (2008)
Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
L. G. de Pillis et al.
MATHEMATICAL BIOSCIENCES (2007)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Blockade of CTLA-4 on CD4+ CD25+ regulatory T cells abrogates their function in vivo
Simon Read et al.
JOURNAL OF IMMUNOLOGY (2006)
Cancer immunotherapy by interleukin-21: Potential treatment strategies evaluated in a mathematical model
Antonio Cappuccio et al.
CANCER RESEARCH (2006)
Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
LG de Pillis et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Normal structure, function, and histology of lymph nodes
Cynthia L. Willard-Mack
TOXICOLOGIC PATHOLOGY (2006)
A validated mathematical model of cell-mediated immune response to tumor growth
LG de Pillis et al.
CANCER RESEARCH (2005)
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
TR Mempel et al.
NATURE (2004)
Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes
MJ Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Lymphocyte populations in human lymph nodes.: Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vβ repertoire
A Battaglia et al.
IMMUNOLOGY (2003)
Expression and regulation of B7 family molecules on macrophages (Mφ) in preterm and term neonatal cord blood and peripheral blood of adults
TW Orlikowsky et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2003)
Dynamic imaging of T cell-dendritic cell interactions in lymph nodes
S Stoll et al.
SCIENCE (2002)
分享论文
